Master blanket purchase agreement for pharmaceutical supplies.
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- HT001424A0002
- Awardee
-
Sofie CO. UEI JV1AHJHGUGG3 Part of Sofie Biosciences, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 21 $2,094,757 obligated
Award facts
- Combined order value
- $2,094,757 Current and potential, with all options
- Last date to order 53% complete
- Maximum order
- $250,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded Sofie CO. (doing business as IBA Molecular), a subsidiary of Sofie Biosciences, Inc., a single-award Blanket Purchase Agreement valued at $1.5 million with a period of performance extending through February 27, 2029. This master BPA, established on February 28, 2024, functions as an indefinite delivery vehicle for pharmaceutical supplies and radiopharmaceutical products supporting the military healthcare system. The contract carries no set-aside designation and reflects Sofie CO.'s established competitive position as a specialized supplier of molecular diagnostics and therapeutic radiopharmaceuticals to federal healthcare agencies. Primary performance is conducted at the contractor's facility in Sterling, Virginia, with certain deliveries directed to Bethesda, Maryland addresses serving Defense Health Agency medical treatment facilities.
The scope of the BPA encompasses provision of positron emission tomography (PET) imaging agents and specialized radiopharmaceuticals critical to diagnostic and therapeutic oncology and neuroendocrine imaging programs across military treatment facilities. Task orders issued under this master agreement have targeted specific radiopharmaceutical products including PYLARIFY (piflufolastat F-18) for prostate cancer detection, NEURACEQ (florbetaben F-18) for Alzheimer's disease imaging, and other proprietary radiopharmaceutical formulations supporting cancer patient diagnostics and treatment monitoring. Individual task order values have ranged from approximately $10,826 to $249,249, with firm fixed-price structures and completion dates aligned with operational medical imaging needs. The BPA establishes a streamlined procurement mechanism enabling the Defense Health Agency to efficiently order specialized radiopharmaceuticals for military personnel, veterans, and their families without requiring individual competitive solicitations, thereby supporting continuity of advanced diagnostic imaging capabilities across the Department of Defense medical system.
Task orders
Show all 21
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Modification | $0 | |
| Other Administrative Action | $0 |
Quick answers
Who was awarded contract HT001424A0002?
HT001424A0002 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on February 28, 2024.
How much is contract HT001424A0002 worth?
Orders under HT001424A0002 have obligated $2,094,757. A single order can be worth up to $250,000.
How many orders have been placed under contract HT001424A0002?
21 orders have been placed under HT001424A0002, the latest on May 26, 2026.
Who can order from contract HT001424A0002?
HT001424A0002 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV